相似文献
1
Editors' Introduction to the Special Section on Ethics, Policy, and Autologous Cellular Therapies.
Perspect Biol Med. 2018;61(1):1-6. doi: 10.1353/pbm.2018.0023.
2
The Need for Beneficence and Prudence in Clinical Innovation with Autologous Stem Cells.
Perspect Biol Med. 2018;61(1):90-105. doi: 10.1353/pbm.2018.0029.
3
A question of ethics: selling autologous stem cell therapies flaunts professional standards.
Stem Cell Res. 2014 Nov;13(3 Pt B):647-53. doi: 10.1016/j.scr.2014.04.014. Epub 2014 Apr 29.
4
The US Direct-to-Consumer Marketplace for Autologous Stem Cell Interventions.
Perspect Biol Med. 2018;61(1):7-24. doi: 10.1353/pbm.2018.0024.
5
Rejuvenating Regenerative Medicine Regulation.
N Engl J Med. 2018 Feb 8;378(6):504-505. doi: 10.1056/NEJMp1715736. Epub 2018 Jan 10.
6
Challenges in the Regulation of Autologous Stem Cell Interventions in the United States.
Perspect Biol Med. 2018;61(1):25-41. doi: 10.1353/pbm.2018.0025.
7
Ethical considerations in the application of cell and gene therapies in children.
S Afr Med J. 2018 Nov 26;108(12):1027-1029. doi: 10.7196/SAMJ.2018.v108i12.13585.
8
Direct-to-consumer marketing of stem cell interventions by Canadian businesses.
Regen Med. 2018 Sep;13(6):643-658. doi: 10.2217/rme-2018-0033. Epub 2018 Sep 26.
9
FDA approves first cell therapy for wrinkle-free visage.
Nat Biotechnol. 2011 Aug 5;29(8):674-5. doi: 10.1038/nbt0811-674.
10
FDA's claims over stem cells upheld.
Nature. 2012 Aug 2;488(7409):14. doi: 10.1038/488014a.
Zotero 插件